Adam Z - Search Results

1

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma.

Ludwig H, Adam Z, Tóthová E, Hajek R, Labar B, Egyed M, Spicka I, Gisslinger H, Drach J, Kuhn I, Hinke A, Zojer N. Ludwig H, et al. Among authors: adam z. Haematologica. 2010 Sep;95(9):1548-54. doi: 10.3324/haematol.2009.020586. Epub 2010 Apr 23. Haematologica. 2010. PMID: 20418244 Free PMC article. Clinical Trial.

2

[Lack of therapeutic effect on primary amyloidosis by interferon-alpha].

Adam Z, Vorlícek J, Králová E, Hájek R, Hejlová N. Adam Z, et al. Acta Med Austriaca. 1994;21(5):137-9. Acta Med Austriaca. 1994. PMID: 7709712 German.

3

[Cisplatin and carboplatin in the treatment of malignant lymphoma and multiple myeloma].

Adam Z, Mayer J, Hájek R. Adam Z, et al. Vnitr Lek. 1994 Dec;40(12):790-800. Vnitr Lek. 1994. PMID: 7839634 Review. Czech.

4

Treatment of refractory multiple myeloma with vincristine, adriamycin, dexamethasone, and with repeated application of cyclophosphamide (C-VAD).

Adam Z, Elbl L, Vorlicek J, Hájek R, Hájek D, Hejlová N, Králová E, Novotná H. Adam Z, et al. Acta Med Austriaca. 1994;21(4):111-5. Acta Med Austriaca. 1994. PMID: 7871966 Clinical Trial.

5

[Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)].

Adam Z, Elbl L, Vorlícek J, Hájek R, Tomíska M, Hejlová N, Králová E, Novotná H. Adam Z, et al. Vnitr Lek. 1994 Aug;40(8):506-12. Vnitr Lek. 1994. PMID: 7941437 Czech.

6

[Difficulties in the therapy of primary amyloidosis].

Adam Z, Elbl L, Vorlícek J, Králová E, Novotná H, Hájek R, Hejlová N. Adam Z, et al. Vnitr Lek. 1994 Sep;40(9):595-9. Vnitr Lek. 1994. PMID: 7975364 Czech.

7

[Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].

Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M. Adam Z, et al. Vnitr Lek. 1995 Nov;41(11):767-72. Vnitr Lek. 1995. PMID: 8553596 Czech.

8

[Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation].

Hájek R, Adam Z, Krejcí M, Vásová I, Král Z, Vorlícek J. Hájek R, et al. Among authors: adam z. Vnitr Lek. 1996 Apr;42(4):278-84. Vnitr Lek. 1996. PMID: 8693716 Review. Czech.

9

[Treatment of multiple myeloma].

Hájek R, Vásová I, Adam Z, Krejcí M, Mayer J, Krahulová M. Hájek R, et al. Among authors: adam z. Vnitr Lek. 1996 May;42(5):345-50. Vnitr Lek. 1996. PMID: 8768295 Review. Czech.

10

Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.

Hájek R, Adam Z, Vásová I, Král Z. Hájek R, et al. Among authors: adam z. Acta Med Austriaca. 1996;23(3):85-91. Acta Med Austriaca. 1996. PMID: 8798281 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters